These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2418490

  • 1. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
    Kahle LH, Avvisati G, Lamping RJ, Moretti T, Mandelli F, ten Cate JW.
    Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
    [Abstract] [Full Text] [Related]

  • 2. Factors and inhibitors of blood coagulation and fibrinolysis in promyelocytic leukemia.
    Bratt G, Blombäck M, Lockner D.
    Scand J Clin Lab Invest Suppl; 1985; 178():81-3. PubMed ID: 3937221
    [No Abstract] [Full Text] [Related]

  • 3. Alpha-2 antiplasmin in acute nonlymphoblastic leukemia.
    Cofrancesco E, Pogliani E, Salvatore M, Moreo G, Boschetti C, Cortellaro M.
    Acta Haematol; 1989; 81(3):122-5. PubMed ID: 2469277
    [Abstract] [Full Text] [Related]

  • 4. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
    Hashizume K, Tanaki T, Horita H, Yoshitani H, Kumatani Y, Matsuda T, Ito K.
    Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
    [No Abstract] [Full Text] [Related]

  • 5. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever).
    Lee M, Kim BK, Kim S, Park S, Han JS, Kim ST, Lee JS.
    Rev Infect Dis; 1989 Feb; 11 Suppl 4():S877-83. PubMed ID: 2568677
    [Abstract] [Full Text] [Related]

  • 6. [Plasma fibronectin in acute myeloid leukemia].
    García Frade LJ, García Avello A, Obispo T, Alava I, Odriozola J, Cesar J, Pardo A, Navarro JL.
    Sangre (Barc); 1984 Feb; 29(4-A):376-83. PubMed ID: 6594781
    [No Abstract] [Full Text] [Related]

  • 7. Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia.
    Velasco F, Torres A, Andres P, Martinez F, Gomez P.
    Thromb Haemost; 1984 Aug 31; 52(1):81-4. PubMed ID: 6238445
    [Abstract] [Full Text] [Related]

  • 8. Automation in coagulation testing. Clinical applications.
    Messmore HL.
    Semin Thromb Hemost; 1983 Oct 31; 9(4):341-5. PubMed ID: 6606852
    [No Abstract] [Full Text] [Related]

  • 9. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
    Asakura H, Saito M, Jokaji H, Uotani C, Kumabashiri I, Matsuda T.
    Rinsho Byori; 1989 Apr 31; Spec No 81():224-8. PubMed ID: 2526885
    [No Abstract] [Full Text] [Related]

  • 10. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 31; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 11. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; measurement with new synthetic substrate method].
    Ujiie M, Kuroiwa K, Nagasawa T, Sato Y, Kitahara N.
    Rinsho Byori; 1989 Apr 31; Spec No 81():208-13. PubMed ID: 2754807
    [No Abstract] [Full Text] [Related]

  • 12. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
    Tsuda T, Hayashi H, Tsurumi N, Kuroda M, Takai Y, Kimura I.
    Rinsho Ketsueki; 1985 Mar 31; 26(3):332-40. PubMed ID: 3162051
    [No Abstract] [Full Text] [Related]

  • 13. [Blood coagulation changes in children with acute myelogenous leukemia: thrombin effect or proteolysis].
    von Kries R, Ebell W, Jürgens H, Göbel U.
    Klin Padiatr; 1984 Mar 31; 196(3):174-7. PubMed ID: 6590923
    [Abstract] [Full Text] [Related]

  • 14. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia.
    Avvisati G, ten Cate JW, Sturk A, Lamping R, Petti MG, Mandelli F.
    Br J Haematol; 1988 Sep 31; 70(1):43-8. PubMed ID: 2460126
    [Abstract] [Full Text] [Related]

  • 15. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R, Seitz R, Blanke H, Leititis J, Kesper HJ, Burghard R, Fuchs G, Lerch L.
    Behring Inst Mitt; 1986 Feb 31; (79):87-103. PubMed ID: 2424425
    [Abstract] [Full Text] [Related]

  • 16. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
    García Frade LJ, García Avello A.
    Sangre (Barc); 1993 Jun 31; 38(3):221-4. PubMed ID: 7692611
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K.
    Rinsho Byori; 1994 Jan 31; 42(1):45-55. PubMed ID: 8107283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.